Previous data from our group showed increased abundance of PCSK 9 in the circulating EVs of rats experiencing good outcomes in a preclinical study of ICH [8], which is in line with the present data showing lower abundance of PCSK9, particularly in macrophage-derived EVs in patients with poor outcomes and infection. Here, PCSK9 is linked to infection.